The Venture Codex Logo

The Venture Codex

Overview

Biotech company developing cell-penetrating therapeutic antibodies.

Total Raised

$221 M

Rounds

4

Links

Verticals

Biotechnology
Health Care
Therapeutics

Investment History

  1. Preferred

    Dec 2025

    $99M

  2. Series B

    Jun 2021

    $84M

  3. Series B

    Jul 2019

    $30M

  4. Series A

    Jun 2017

    $8M

Team

Sung Joo LEE

CEO & Founder

Yong Sung KIM,

Scientific &Co- Founder

Peter U. Park

Chief Scientific Officer

Olaf Christensen

Chief Medical Officer